Kerala Ayurveda share news, announcements and annual reports
BSE: 530163Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹139.60.
30 Oct: open ₹144.35, high ₹144.35, low ₹137.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹192 Cr2,181st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −257.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −24.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 5.43
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,685
Kerala Ayurveda share news and announcements
558 announcements, routine notices left out, newest first. Page 5 of 12.
May 2023
23 May · Board meeting
Meeting on 30 May 2023: quarterly results11 May · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
8 May · Board meeting
Meeting on 11 May 2023: preferential issue of shares
Apr 2023
18 Apr · Certificate Under Reg.40
3 Apr · Compliance Certificate For The Year Ended 31St March, 2023
Feb 2023
14 Feb · Business
14 Feb · Management
6 Feb · Board meeting
Meeting on 14 Feb 2023: quarterly results
Dec 2022
Nov 2022
14 Nov · Business
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
12 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
29 Sep · Management
28 Sep · Meeting
28 Sep · Meeting
28 Sep · Meeting
28 Sep · Meeting
27 Sep
6 Sep · Reg. 34 (1) Annual Report.
1 Sep · Meeting
Aug 2022
4 Aug · Board meeting
Meeting on 12 Aug 2022: quarterly results
Jul 2022
11 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
28 Jun · Board meeting
23 Jun · Board meeting
Meeting on 28 Jun 2022
May 2022
23 May · Board meeting
Meeting on 30 May 2022: audited results and quarterly results
Apr 2022
6 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2022
30 Mar · Disclosure In Terms Of Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), 2015 Regarding WP(C) No. 4024 Of 2022 Filed By Katra Holding Pvt Ltd Before Hon'Ble High Court Of Kerala Relating To Company Appeal (AT)(CH)(INS)11 Of 2022 Filed With Hon'Ble National Company Law Appellate Tribunal, Chennai And In IBA 46/KOB/2019 Before Hon'Ble NCLT, Kochi And CMP 267/2021 Before Hon'Ble High Court Of Karnataka Between Tata Global Beverages Ltd And Kerala Ayurveda Ltd
21 Mar · Disclosure In Terms Of Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), 2015 Regarding Company Appeal (AT)(CH)(INS)11 Of 2022 Before The Hon'Ble National Company Law Appellate Tribunal, Chennai And In IBA 46/KOB/2019 Before The Hon'Ble NCLT, Kochi And CMP 267/2021 Before The Hon'Ble High Court Of Karnataka Between Tata Global Beverages Ltd. And Kerala Ayurveda Ltd.
Feb 2022
14 Feb · Board meeting
7 Feb · Board meeting
Meeting on 14 Feb 2022: quarterly results